Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride in Intermittent Androgen Ablation for Prostate Cancer
NCT00668642Phase 2Completed
- Sponsor
- Endeavor Health
- Start
- Mar 2007
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dutasteride in prostate cancer (PCa), sponsored by Endeavor Health. Started Mar 2007; status: completed.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00668642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668642.